Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC3535 Myrtucommulone

Inhibitor of the chaperonin activity of HSP60, correlating to LONP and LRP130 aggregation

54247-21-1
DCC3536 Myxopyronin A

Bacterial RNA polymerase (RNAP) inhibitor

88192-98-7
DCC3537 Mzp-54

Novel potent and selective PROTAC degrader of BRD3/4

2010159-47-2
DCC3538 N,n-dimethylsphingosine

Competitive inhibitor of both SPHK1 and SPHK2

119567-63-4
DCC3539 n00236460

Glucokinase activator (GKA)

1466419-40-8
DCC3540 N6-allyladenosine

Novel RNA labeling probe through both metabolic and enzyme-assisted manners

15763-12-9
DCC3541 N6-methyl-d3-adenosine

Deuterium labeled m6A used in important m6A physiological pathways related studies

139896-43-8
DCC3542 Na-aaf

Alkylating agent, forming DNA adducts at the C-8 position in guanine, resulting in single strand breaks, demonstrating carcinogenic action

6098-44-8
DCC3543 Nabiximols

Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) combination for the treatment of multiple sclerosis (MS)-related moderate to severe spasticity

56575-23-6
DCC3544 N-acetylloline

Derivative of loline

4914-36-7
DCC3545 N-adamantanylglycinamide Hbr

Novel antiviral agent against the replication of influenza virus A/H3N2 subtype in Madin-Darby canine kidney (MDCK) cells

54993-13-4
DCC3546 Nadide

Coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage

53-84-9
DCC3547 Nadph Tetrasodium Salt

Electron donor and cofactor for many redox enzymes including nitric oxide synthetase

2646-71-1
DCC3548 Nafoxidine

Partial estrogen antagonist, inhibiting angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF), inducing oxidative stress, protein kinase C and calcium signaling

1845-11-0
DCC3549 Nag-26

Novel potent full agonist for orexin receptor

DCC3550 Nai003

Novel highly selective antibacterial agent against Propionibacterium acnes

1888304-21-9
DCC3551 Nalbuphine Hydrochloride

Mixed agonist/antagonist opioid modulator, binding with high affinity to the MOR and KOR, and having relatively low affinity for the DOR

23277-43-2
DCC3552 Naph-o2

Novel fluorescent probe for detection of endogenously produced Naph-O2˙– in living cells and tissues

DCC3553 Naphthyridine-azaquinolone

Novel repeat-structure-specific DNA ligand, specifically binding slipped-CAG DNA intermediates of expansion mutations

DCC3554 Naphyrone Hydrochloride

Triple reuptake inhibitor

850352-11-3
DCC3555 Napi2b Inhibitor 15

Novel Gut-Restricted Inhibitor of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia

DCC3556 Napitane Mesylate

Antagonist of alpha-2 adrenergic receptors and inhibitor of the neuronal uptake of norepinephrine

149189-73-1
Page 1383 / Total 1558 FirstPrevNextLastGoto